Low Frequency of Meperidine-Associated Seizures in Sickle Cell Disease

Abstract

Pain control measures in sickle cell diseases are not uniform. Most clinicians use parenteral morphine or meperidine for severe pain. Reports of seizures associated with meperidine have led to a growing reliance on intravenous morphine, usually with patient-controlled devices. Acceptance of morphine has been poor among patients, and many prefer meperidine. The aim of this retrospective study was to determine the incidence of meperidine-associated seizures in a large, mostly pediatric population with sickling disorders. The results suggest that the incidence of seizures with meperidine is extremely small (0.4% of patients; 0.06% of admissions). The risk of seizures should not dissuade clinicians from using this drug.

Get full access to this article

View all access options for this article.

References

1. Pegelow CH . Survey of pan manage ment therapy provided for children with sickle cell disease. Clin Pediati. 1992;31:211-214.

2. Tang R , Shimomura SK , Rotblatt M . Meperidine-induced seizures in sickle cell patients. Hosp FoEr mln. 1980;15: 764-772.

3. Shimomura SK , Harris S . Pain management of patients with sickle cell anemia. Hosp Pliarmacq. 1979;14:332-336.

4. Pryle qj , Grech H , Stoddart PA , et al. Toxicity of norpethidine in sickle cell crisis. Bi Medj. 1992;304:1478-1479.

5. Hagmexer KO , Matiio LS , Mauro XF . Meperidine-related seizures associated xsith patient-controlled analgesia pumps. Ann Pliarimacolier. 1993;27:29-32.

6. Harrison JFM , Leisner R , Davies SC . Pethidine in sickle cell crisis. Br illedj 1992;305:182-182.

7. Kyff JV , Rice TL . Meperidine-associated seizures in a child. Clini P/ilarsaa col. 1990;9:337-338.

8. Richardson P , Steingart R . Meperidine and ketorolac in treatment of painful sickle cell crisis (letter). Ann Isneig Wed. 1993;22:1639-1640.

9. McPherson E , Perlin E , Finke H , et al. Patient-controlled analgesia in patients with sickle cell vasoocclusive crisis. AmJMed Sci. 1990;229:10-12.

10.

10. LirijE , Gzesh DJ , Ballas SK . The spectrum of epilepsy in sickle cell anemia. J Veuiol Sci. 1994;123:6-10.

11.

11. Adamolekun B , Durosinmi MA , Olowu W , Aderiran I . The prevalence and classification of epileptic seizures in Nigerians xxith sickle cell anemia. J Trop MiN Hyg. 1993;96:288-290.

12.

12. Hauser WA . Epidemiology of epilepsy. Adv NeeuroL. 1978;19:313-339.

13.

13. Hauser WA , Hesdorfferr DC . Epilepsy: Frequency, Causes and Consequensces. Maryland: Epilepsy Foundation of America; 1990:1-51.

14.

14. Hauser WA , Kuland LT . The epidemiology of epilepsy in Rochester, Minnesota: 1935 through 1967. Epilepsia. 1975;16:1-66.

15.

15. Hauser WA , Annegers JF , Kurland LT . Prevalence of epilepsy in Rochester, Minnesota: 1940 through 1980. Epilepsia. 1991;32:429-445.

16.

16.Goodman and Gillman 's The Pharmacological Basis of Therapeutics, 9th ed. Newe York: McGraw-Hill; 1996:532-532.

17.

17.Avery's Drag Treatment, 4th ed. Auckland: Adis International; 1997:494-495.